AOR, Curcumin Active, 60 softgels
Cureself Customer Service
Curcumin Active - 60 softgels, aor vitamins supplements
AOR, Curcumin Active, 60 softgels is manufactured by AOR Supplements
- FAST ACTING for quick relief of pain and inflammation
- At least 100 TIMES more bioavailable than standard curcumin extracts
- Each 133mg capsule is EQUIVALENT TO OVER 13g of a standard curcumin extract
- Clinically proven effectiveness and bioavailability
Curcuma longa is traditionally used in
Herbal medicine as an anti-inflammatory to help relieve joint pain and
provides antioxidants for the maintenance of good health.
|Serving Size: 1 Capsule
|Longvida® Optimized Curcumin* (from Curcuma longa root 25-30:1)
|Non-medicinal ingredients: ascorbyl palmitate, microcrystalline cellulose, soy lecithin, stearic acid, maltodextrin, silicon dioxide. Capsule: hypromellose. *LONGVIDA® is a registered trademark of Verdure Sciences Inc. International patent pending.
that no ingredients not listed on the label have been added to the
product. Contains no wheat, gluten, nuts, peanuts, sesame seeds,
sulphites, mustard, eggs, dairy, fish, shellfish or any animal
Adult Dosage: Take 1 to 2 capsules daily, or as directed by a qualified health care practitioner.
Consult a health care practitioner prior to use if you are taking
antiplatelet medication or blood thinners, or if you have gallstones, a
bile duct obstruction, stomach ulcers or excess stomach acid. Consult a
health care practitioner if symptoms persist or worsen.
Pregnancy/Nursing: Consult a health care practitioner prior to use
100% pure curcumin from Longvida® Optimized Curcumin
- Auto-immune diseases
- Alzheimer’s disease
- Lipid Metabolism
- Gastrointestinal Health
Do Not Confuse Turmeric Root with Curcumin!
is a powerful anti-inflammatory derived from turmeric root. Due to its
widespread mechanisms of action, curcumin has been studied for
conditions such as cancer, Alzheimer’s disease, irritable bowel disease
(IBD), colitis, diabetes, rheumatoid arthritis, viral infections such as
hepatitis, drug-resistant bacterial infections, healing of skin
conditions, and more.
Researchers recommend taking a dose of 3 to 4
g of 95% curcumin per day in order to obtain any health benefits like
pain relief, inflammation reduction, or improvements to heart health or
diabetes. This 3-4 g dose is equivalent to taking 7 to 10 capsules of
curcumin 95%, or between twenty to thirty capsules of a high potency 750
mg 10:1 ratio extract of turmeric root! Clearly taking this amount of
capsules per day is unreasonable.
Longvida, a highly bioavailable
form of curcumin, is the result of testing over two hundred
formulations and has taken more than ten years to develop. In a human
study on cancer patients, Longvida® curcumin was shown to be over 100
times more bioavailable than regular curcumin. This formulation was
developed and patented by UCLA Medical School and is licensed
exclusively to Advanced Orthomolecular Research (AOR).
Other benefits are:
133 mg capsule is equivalent to over 13 g of curcumin. This would
require taking 33 capsules of regular 95% curcumin extract or more than
100 capsules of 750 mg turmeric root extract!
- Vegan formula
- NPN Granted
root supplements absolutely do not offer the same benefits as those
containing isolated curcumin. Curcumin is the most potent component of
the turmeric root. Unfortunately, turmeric root contains less than 2% of
curcumin making it ineffective for any health benefits. In addition,
over 95% of all clinical studies have been conducted using isolated
curcumin and NOT with the turmeric root. Even 750mg of a 10:1 ratio
extract of turmeric will deliver no more than 150mg of the active
curcumin. But given the poor bioavailability (the amount of the active
compound that reaches the target site or site of action) of this
compound, the amount you actually get is likely far less than that.
Clinical studies suggest that the bioavailability is less than 5%,
making even standard 95% curcumin formulations fairly ineffective. As
for a significantly weakened turmeric root formula? That becomes
is currently being heavily studied for use as an adjunct to
conventional cancer treatments. Unfortunately, most of the studies have
noted minimal results despite promising in vitro and animal studies.
Researchers have recognized that the cause for the poor results is
curcumin’s poor bioavailability.
and colleagues did a safety and bioavailability study on healthy
volunteers and patients with non-responsive bone cancer. Subjects were
given doses between 400 and 1,200 mg of curcumin in solid lipid particle
form (equivalent to 3 to 9 capsules of Curcumin Active). All doses
showed significant absorption into the bloodstream over 8 hours with no
adverse events. This is especially significant since previous studies
giving 8,000-12,000 mg of pure regular curcumin barely showed any blood
levels or clinical improvements. In addition, the 1,200 mg dose
produced blood levels of curcumin necessary to reduce isoprostanes,
TNF-α, and amyloid-β, which are markers for diseases like cancer and
is also significant interest in its ability to reduce amyloid-β plaque,
which is thought to be a causative factor of Alzheimer’s disease. In
vitro and animal studies have shown that curcumin can significantly
reduce levels of amyloid-β and preserve Alzheimer model animal memory.
Finally, a recent human study has shown that just 80 mg of curcumin can
reduce amyloid-β in humans. The curcumin that was finally able to do so
was Longvida® curcumin SLP, and in just one month.
Longvida Curcumin in Humans
human trial on curcumin showed statistically significant effects on
clinical endpoints in a healthy population. The fact that such a low
dose (80 mg) was needed to achieve effects in only 30 days is an
interesting and unique finding as well, and adds to the substantial
amount of pharmacokinetic and pharmacodynamic data compiled on
Longvida®. The results of the study suggest that curcumin can produce
beneficial effects in people who are without immediate disease states.
The study was conducted on 38 healthy middle aged people between the age
of 40 and 60 who were either given a dose of 80 mg/day of Longvida®
curcumin extract for four weeks or were a part of the 19 person placebo
group. The study is particularly interesting because the relatively
small dose of curcumin, from Longvida® which was used, exerted a variety
of health promoting effects leading researchers to presume that a
significant amount of the curcumin was absorbed, although not tested
Blood sample readings collected from test subjects to
assess nitric oxide and sICAM molecules which are relevant to assessing
cardiovascular risk and related to blood pressure and atherosclerosis,
were notably affected by the curcumin. Both readings corresponded to a
decreased risk of cardiovascular disease. The study also indicated that
curcumin may have a positive effect on liver health maintenance as was
noted from the reduction of indicators used to mark liver injury.
Participants had lowered levels of triglycerides which relates to other
research demonstrating that cholesterol could potentially be lowered in
relatively healthy persons given higher dosages of the substance, thus
benefiting those with or at risk of having cardiovascular disease.
other markers of inflammation and free radicals/toxic species that
cause inflammation and damage to cells were also significantly lowered.
Both direct and indirect antioxidant actions of curcumin were evident in
the subjects; these findings are consistent with in vitro and animal
studies used to measure increases in curcumin induced antioxidant enzyme
supplements on the market contain the curcumin extract of turmeric.
However, many of these are poorly absorbed and offer little value in
terms of therapeutic benefit due to their poor bioavailability.
New Technology – Better Products!
Over the last ten years a great deal of research has been done to
develop formulations that improve the bioavailability of curcumin. The
goal has been to deliver more of the active molecules to the body in a
much lower daily dose; as few as one to three capsules per day. There
have been a number of technologies developed, but the one that has
provided the most compelling evidence is nano-technology.
Longvida curcumin was introduced to Canada exclusively
by AOR in 2011. Curcumin Active is clinically proven to deliver several
health benefits as a result of its higher bioavailability over regular
curcumin supplements and has the following advantages:
tested with results published in 2010 in the prestigious Journal of
Agricultural and Food Chemistry. In the study, patients with cancer of
the bone experienced few to no adverse effects and good tolerability of
the equivalent of up to 9 capsules of Curcumin Active.
- A 100-fold increase in bioavailability compared to regular curcumin.
- Patented by the University of California
- Published study showing positive effects in reducing beta-amyloid levels in humans
consists of solid lipid particles (SLP) which are tiny nano-sized (1
billionth of a meter) particles that have a protected layer that
provides a phenomenal increase in stability, potency and effectiveness.
Unlike regular curcumin that is easily broken down by stomach acids,
Curcumin Fast Relief particles are resistant to acid breakdown. Even
more important is the fact that these tiny particles are absorbed very
rapidly. This means that they deliver all of the health benefits of
curcumin, including pain relief, reduced inflammation, antioxidant
properties and other effects much faster than any other curcumin
Try Curcumin Active today and start feeling the benefits of a real high-potency, high-bioavailability curcumin supplement.
Begum et al. Curcumin Structure-Function, Bioavailability, and Efficacy in Models of Neuroinflammation and Alzheimer’s Disease. J Pharmacol Exp Ther. 2008 Jul;326(1):196-208.
P, Patel C, Muchhara J, Bhadja N, Mathuria N, Vachhani K, Soni MG.
Chronic safety of Longvida. Food Chem Toxicol. 2011 May 6.
Write a useful product review, and get a personal coupon or gift card for your order!
Search by Brand
CAD/USD Exchange Rate